AGD members are using the population-level insights to uncover novel drug targets SAN DIEGO, /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

Sampling operations were executed by trained professionals under strict aseptic conditions and a uniform protocol ... MA). Sequencing libraries were constructed with the sheared fragments using TruSeq ...

Genomic DNA was extracted and sequenced using the Illumina NovaSeq ... WGS continue to diminish, whole-genome sequencing is likely to replace targeted PCR approaches for species identification and ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

The Advances in Genome Biology and Technology (AGBT ... She also shares industry insights from companies like Illumina, Bruker, and Pixelgen.

"Illumina has set the standard in whole genome sequencing, and now, with Broad's deep experience and long history of translating complex molecular biology assays into high-throughput, high quality ...

The first human genome was sequenced in 2003 after 13 years of hard work, for a cost of $3B. Quickly, full-genome sequencing started to ... as their existing research or medical protocols are ...

Illumina’s technology helped reduce the cost of whole genome sequencing faster than Moore’s law in semiconductors--to $1,000 by 2014. This pace of cost reduction and innovation has been ...